BM-derived CD34+ HSPCs from individuals with MDS showed significantly higher ALPK1 mRNA levels compared with the age-matched controls (Fig. 3g), correlating with a worse prognosis (Fig. 3h). This evidence concerns the gene CD34 and myelodysplastic syndrome.